Pantau & Analisa Saham Lebih MudahDownload InvestSaham App
Healthcare
Alnylam Pharmaceuticals, Inc.
$331
+4.68%Annual Revenue
| Period | Revenue | YoY |
|---|---|---|
| 2025 | $3.71B- | - |
Annual Net Income
| Period | Net Income | YoY |
|---|---|---|
| 2025 | $313.75M- | - |
Quarterly (Last 10 Years)
| Metric | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 |
|---|---|---|---|---|---|
| Quarterly Revenue |
Scan IHSG & NASDAQ stocks in real-time and find opportunities quickly.
⚡Intraday Screener
Track real-time price movement today
Support 2
$298
-89.44%
EPS History
| Year | EPS |
|---|---|
| 2022 | -9,3 |
| 2023 | -3,52 |
| 2024 | -2,18 |
| 2025 | 2,33 |
Simple estimate: Fair Value = EPS x PER 15. Use the Fair Value Calculator for detailed analysis.
3.71 B
Total Asset
4.97 B
Cash Flow
524.08 M
Avg Volume
1.33 M
8.45%
$1.10B- |
$1.25B- |
$773.69M- |
$594.19M- |
| - |
| Quarterly Net Income | $186.42M+322.6% | $251.08M- | $-66.28M- | $-57.48M- | $-83.76M- |
Discounted
Below fair value
